NEW YORK (GenomeWeb News) – Illumina reported after the close of the market Monday that its first-quarter revenues increased 21 percent year over year as the firm swung to a loss due to litigation-related charges.

The San Diego-based firm posted revenues of $331 million for the three months ended March 31, compared to $272.8 million for the first quarter of 2012. It beat the average analyst estimate of $310.7 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: new gene linked to ocular coloboma, new statistical model for interrogating gene expression networks, and more.

With a new collection, PLOS highlights negative results it has published.

A pair of researchers examines political leanings and views on genomics, finding more of a role for optimism and pessimism in people's views.

The genome of the carnivorous bladderwort is smaller than many other plant genomes, but it still holds on to important genes.